CANFCan-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares

ADRCNYSE American, LLC (XASE)·USD

Identity

Security key: 13087
Ticker: CANF
Type: ADRC — American Depository Receipt Common
Exchange: NYSE American, LLC(XASE)
Venue group: NYSE
Operating MIC: XNYS
Market: stocks
Locale: us
Currency: USD
Listed: 2012-09-10
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: CANF

Detail

Enriched 2026-08-14 20:47

Market cap: $7,370,361.68
Shares outstanding (class): 2,142,547
Shares outstanding (weighted): 2,142,547
SIC: —
Employees: 5
Location: —
Homepage: https://www.canfite.com
Description: Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Market cap and share counts drift.

Funds holding this security

1 funds · 1 positions · $155.00 reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$155.00	0.00%	50 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERCANF
FIGI_COMPOSITEBBG003CMFDM2
FIGI_SHARE_CLASSBBG003CMFFC8
CIK0001536196
ISINUS13471N4097
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Can-Fite BioPharma is a clinical-stage biopharmaceutical company, so it is classified as equity in the healthcare sector, biotechnology industry.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.